These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22855171)

  • 1. Multicenter validation of two nomograms to predict non-sentinel node involvement in breast cancer.
    Piñero A; Canteras M; Moreno A; Vicente F; Giménez J; Tocino A; Iglesias E; Vidal-Sicart S; Santamaría L; Lorenzo M; García M; Ramirez D;
    Clin Transl Oncol; 2013 Feb; 15(2):117-23. PubMed ID: 22855171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting non-sentinel lymph node status after positive sentinel biopsy in breast cancer: what model performs the best in a Czech population?
    Coufal O; Pavlík T; Fabian P; Bori R; Boross G; Sejben I; Maráz R; Koca J; Krejcí E; Horáková I; Foltinová V; Vrtelová P; Chrenko V; Eliza Tekle W; Rajtár M; Svébis M; Fait V; Cserni G
    Pathol Oncol Res; 2009 Dec; 15(4):733-40. PubMed ID: 19440855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.
    Tanaka S; Sato N; Fujioka H; Takahashi Y; Kimura K; Iwamoto M
    Surg Today; 2013 Feb; 43(2):163-70. PubMed ID: 22722328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An independent assessment of the 7 nomograms for predicting the probability of additional axillary nodal metastases after positive sentinel lymph node biopsy in a cohort of British patients with breast cancer.
    Nadeem RM; Gudur LD; Saidan ZA
    Clin Breast Cancer; 2014 Aug; 14(4):272-9. PubMed ID: 25037530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of an existing and modified model for predicting non sentinel lymph node metastasis in breast cancer patients with positive sentinel node biopsy.
    Al-Masri M; Darwazeh G; El-Ghanem M; Hamdan B; Sughayer M
    Gulf J Oncolog; 2013 Jan; 1(13):15-22. PubMed ID: 23339977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.
    Bonsang-Kitzis H; Mouttet-Boizat D; Guillot E; Feron JG; Fourchotte V; Alran S; Pierga JY; Cottu P; Lerebours F; Stevens D; Vincent-Salomon A; Sigal-Zafrani B; Campana F; Rouzier R; Reyal F
    PLoS One; 2017; 12(2):e0169962. PubMed ID: 28241044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.
    van la Parra RF; Francissen CM; Peer PG; Ernst MF; de Roos WK; Van Zee KJ; Bosscha K
    Eur J Cancer; 2013 Feb; 49(3):564-71. PubMed ID: 22975214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of Memorial Sloan Kettering Cancer Center nomogram to detect non-sentinel lymph node metastases in a United Kingdom cohort.
    Syed A; Eleti S; Kumar V; Ahmad A; Thomas H
    G Chir; 2018; 39(1):12-19. PubMed ID: 29549676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy.
    Scomersi S; Torelli L; Zanconati F; Tonutti M; Dore F; Bortul M
    Ann Ital Chir; 2012; 83(6):461-8. PubMed ID: 23110902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.